CAREDX, INC. Restricted Cash and Cash Equivalents, Noncurrent
CAREDX, INC. (CDNA) had Restricted Cash and Cash Equivalents, Noncurrent of $521.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2026-07-30
- 2026-06-30: Restricted Cash and Cash Equivalents, Noncurrent $521.00K.
- 2026-03-31: Restricted Cash and Cash Equivalents, Noncurrent $551.00K.
- 2025-12-31: Restricted Cash and Cash Equivalents, Noncurrent $551.00K.
- 2025-09-30: Restricted Cash and Cash Equivalents, Noncurrent $551.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2026-06-30 | $521.00K 10-Q · filed 2026-07-30 |
| 2026-03-31 | $551.00K 10-Q · filed 2026-04-28 |
| 2025-12-31 | $551.00K 10-Q · filed 2026-07-30 |
| 2025-09-30 | $551.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $551.00K 10-Q · filed 2026-07-30 |
| 2025-03-31 | $550.00K 10-Q · filed 2026-04-28 |
| 2024-12-31 | $585.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $592.00K 10-Q · filed 2025-11-04 |
| 2024-06-30 | $588.00K 10-Q · filed 2025-08-06 |
| 2024-03-31 | $583.00K 10-Q · filed 2025-04-30 |
| 2023-12-31 | $586.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $582.00K 10-Q · filed 2024-11-04 |
| 2023-06-30 | $584.00K 10-Q · filed 2024-07-31 |
| 2023-03-31 | $520.00K 10-Q · filed 2024-05-09 |
| 2022-12-31 | $522.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $198.00K 10-Q · filed 2023-11-08 |
| 2022-06-30 | $204.00K 10-Q · filed 2023-08-08 |
| 2022-03-31 | $214.00K 10-Q · filed 2023-05-10 |
| 2021-12-31 | $211.00K 10-K · filed 2023-02-27 |
| 2021-09-30 | $210.00K 10-Q · filed 2022-11-03 |
| 2021-06-30 | $268.00K 10-Q · filed 2022-08-04 |
| 2021-03-31 | $269.00K 10-Q · filed 2022-05-05 |
| 2020-12-31 | $270.00K 10-Q · filed 2022-05-05 |
| 2020-09-30 | $260.00K 10-Q · filed 2021-10-28 |
| 2020-06-30 | $253.00K 10-Q · filed 2021-07-29 |
| 2020-03-31 | $242.00K 10-Q · filed 2021-05-05 |
| 2019-12-31 | $256.00K 10-Q · filed 2021-10-28 |
| 2019-09-30 | $251.00K 10-Q · filed 2019-10-31 |
| 2019-06-30 | $255.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $191.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $192.00K 10-K · filed 2020-02-28 |
| 2018-09-30 | $192.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $177.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $206.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $9.58M 10-K · filed 2019-03-06 |
| 2017-09-30 | $9.55M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $9.55M 10-Q · filed 2017-08-11 |
| 2017-03-31 | $9.55M 10-Q · filed 2017-06-09 |
| 2016-12-31 | $143.00K 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |